Erasmus MC Cancer Institute introduces comprehensive DNA testing for CUP cancer patients in EMBRAZE region
The Erasmus MC Cancer Institute has started using comprehensive DNA testing for carcinoma of unknown primary (CUP) cancer patients in the EMBRAZE region. The test identifies which patients are suited for standard cancer treatments, and which patients could benefit from experimental treatments. EMBRAZE is a cancer care network in the provinces of North Brabant and Zeeland.
More information
You read an article in the category Billing code. You may also be interested in Cancer of Unknown Primary, OncoAct or Participating hospitals.All news
Also read
Hartwig receives CE certification for OncoAct, the first complete IVDR-certified whole-genome cancer diagnostics solution
We are proud to announce that Hartwig Medical Foundation has received CE certification under the European In Vitro Diagnostic Regulation …
In the media: Genomeweb: Partial reimbursement for comprehensive DNA test in the Netherlands
This week, Genomeweb’s Precision Oncology News brought the news that the Dutch House of Representatives has recently unanimously decided to …
Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs
A one-time analysis of the entire tumor DNA is almost always sufficient to find all DNA errors that may be …
The number of WGS samples Hartwig Medical Foundation has is quite unique in the research field and is rapidly growing. It amounted to 3.500 samples when we started and it’s already over 5.000 now.